Chengyi Li

Title: Innovations of Chengyi Li in Nano-Satellite Complexes

Introduction

Chengyi Li is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of nanotechnology, particularly in the development of nano-satellite complexes. His innovative work aims to enhance cancer treatment through advanced biocompatible systems.

Latest Patents

Chengyi Li holds a patent for his invention titled "Nano-satellite complexes." This invention provides methods, compositions, systems, and kits that include nano-satellite complexes. These complexes consist of a core nanoparticle complex with a biocompatible coating surrounding a nanoparticle core. Additionally, they feature 3-25 satellite particles attached to or absorbed by the biocompatible coating, along with a plurality of antigenic peptides conjugated to or absorbed by the satellite particles. In some embodiments, the administration of these nano-satellite complexes to subjects with cancer can achieve long-term cancer remission, especially when combined with immune checkpoint inhibitors like αPD1. Chengyi Li has 1 patent to his name.

Career Highlights

Chengyi Li is affiliated with the University of Michigan, where he continues to push the boundaries of research in nanotechnology and its applications in medicine. His work is characterized by a commitment to developing innovative solutions that can significantly impact cancer treatment.

Collaborations

Chengyi Li collaborates with notable colleagues such as Duxin Sun and Ryan Clauson. Their combined expertise contributes to the advancement of research in the field of nano-satellite complexes.

Conclusion

Chengyi Li's innovative work in nano-satellite complexes represents a promising advancement in cancer treatment. His contributions to the field of nanotechnology are paving the way for new therapeutic strategies that could improve patient outcomes.